The global mycoplasma testing market is projected to grow at a robust 11% CAGR from 2022 to 2027. Key drivers include ...

Urban areas face unprecedented challenges due to climate change, biodiversity loss, and rapid population growth. In this ...

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or ...

Company Accelerates Phase 2 Alzheimer's Program and Gains National Institute on Aging (NIA) Recognition for AI Leadership ...

The growth of the thin-film electrode market is being fueled by the expanding role of advanced materials in biotechnology, renewable energy, and smart electronics, coupled with rising opportunities ...

(NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs ...

CF602 is a novel A3AR allosteric modulator that enhances the receptor activity in the presence of the native ligand. The molecule is characterized by high selectivity at the A3AR and is capable of ...

The provisional patent application, titled, “Raphael Pharmaceutical, Inc. / Rambam MedTech Formula for Treating Neutrophil-Dominant Autoimmune Diseases (including RA)” (No. 63/911,729), was filed ...

Film Electrode Market by Material (Metal Based, Boron-Doped Diamond Based, Carbon Based, Polymer Based, Other Materials), Manufacturing Facility (Physical Vapor Deposition, Chemical Vapor Deposition, ...

Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR? Antagonist, Phase 3-ready) and ...

The S&P 1500 Health Care Index gained 1.9% in September, underperforming the S&P 500, which advanced 3.7%. Read more here.

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company’s transition to a fully ...